Journal articles on the topic 'VEGF, HYPERTENSION'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'VEGF, HYPERTENSION.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Grover, Theresa R., Thomas A. Parker, Jeanne P. Zenge, Neil E. Markham, John P. Kinsella, and Steven H. Abman. "Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus." American Journal of Physiology-Lung Cellular and Molecular Physiology 284, no. 3 (March 1, 2003): L508—L517. http://dx.doi.org/10.1152/ajplung.00135.2002.
Full textMarini, M., D. Vichi, A. Toscano, G. D. Zappoli Thyrion, E. Parretti, G. Mello, G. Gheri, A. Pacini, and E. Sgambati. "Expression of vascular endothelial growth factor receptor types 1, 2 and 3 in placenta from pregnancies complicated by hypertensive disorders." Reproduction, Fertility and Development 19, no. 5 (2007): 641. http://dx.doi.org/10.1071/rd06131.
Full textKobalava, Zh D., and E. K. Shavarova. "Hypertension related to the antitumor treatment with angiogenesis inhibitors: an iatrogenic hypertension." "Arterial’naya Gipertenziya" ("Arterial Hypertension") 24, no. 4 (September 26, 2018): 384–95. http://dx.doi.org/10.18705/1607-419x-2018-24-4-384-395.
Full textLouzier, Vanessa, Bernadette Raffestin, Aude Leroux, Didier Branellec, Jean Michel Caillaud, Micheline Levame, Saadia Eddahibi, and Serge Adnot. "Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension." American Journal of Physiology-Lung Cellular and Molecular Physiology 284, no. 6 (June 1, 2003): L926—L937. http://dx.doi.org/10.1152/ajplung.00247.2002.
Full textBhargava, Pankaj. "VEGF kinase inhibitors: how do they cause hypertension?" American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 297, no. 1 (July 2009): R1—R5. http://dx.doi.org/10.1152/ajpregu.90502.2008.
Full textPearson, Roy Douglas. "Placental Malaria: Hypertension, VEGF, and Prolactin." PLoS Medicine 4, no. 3 (March 27, 2007): e141. http://dx.doi.org/10.1371/journal.pmed.0040141.
Full textHayman, Suzanne R., Nelson Leung, Joseph P. Grande, and Vesna D. Garovic. "VEGF Inhibition, Hypertension, and Renal Toxicity." Current Oncology Reports 14, no. 4 (April 29, 2012): 285–94. http://dx.doi.org/10.1007/s11912-012-0242-z.
Full textNewton, Herbert B. "Bevacizumab: Review of Development, Pharmacology, and Application to Brain Tumors." Clinical Medicine. Therapeutics 1 (January 2009): CMT.S2042. http://dx.doi.org/10.4137/cmt.s2042.
Full textLe Cras, Timothy D., Neil E. Markham, Rubin M. Tuder, Norbert F. Voelkel, and Steven H. Abman. "Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure." American Journal of Physiology-Lung Cellular and Molecular Physiology 283, no. 3 (September 1, 2002): L555—L562. http://dx.doi.org/10.1152/ajplung.00408.2001.
Full textYang, Guo-Hong, Xin Zhou, Wen-Jie Ji, Shan Zeng, Yan Dong, Lu Tian, Ying Bi, et al. "Overexpression of VEGF-C attenuates chronic high salt intake-induced left ventricular maladaptive remodeling in spontaneously hypertensive rats." American Journal of Physiology-Heart and Circulatory Physiology 306, no. 4 (February 15, 2014): H598—H609. http://dx.doi.org/10.1152/ajpheart.00585.2013.
Full textTSAI, Wei-Chuan, Yi-Heng LI, Yao-Yi HUANG, Chin-Chan LIN, Ting-Hsing CHAO, and Jyh-Hong CHEN. "Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension." Clinical Science 109, no. 1 (June 23, 2005): 39–43. http://dx.doi.org/10.1042/cs20040307.
Full textTang, Jen-Ruey, Gregory J. Seedorf, Vincent Muehlethaler, Deandra L. Walker, Neil E. Markham, Vivek Balasubramaniam, and Steven H. Abman. "Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin." American Journal of Physiology-Lung Cellular and Molecular Physiology 299, no. 6 (December 2010): L735—L748. http://dx.doi.org/10.1152/ajplung.00153.2010.
Full textGoodlett, Bethany L., Chang Sun Kang, Eunsoo Yoo, Shobana Navaneethabalakrishnan, Dakshnapriya Balasubbramanian, Sydney E. Love, Braden M. Sims, et al. "A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice." Pharmaceutics 14, no. 1 (December 30, 2021): 84. http://dx.doi.org/10.3390/pharmaceutics14010084.
Full textKatsi, Vasiliki, Zerdes Ioannis, Manolakou Stavroula, Makris Thomas, Nihoyannopoulos Petros, Tousoulis Dimitris, and Kallikazaros Ioannis. "Anti-VEGF Anticancer Drugs: Mind the Hypertension." Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) 9, no. 2 (July 30, 2015): 63–72. http://dx.doi.org/10.2174/1574890110999150604114127.
Full textBadri, Shirinsadat, Lillian Siberian, Rasool Soltani, Azadeh Moghaddas, Sara Ataei, and Mahnaz Momenzadeh. "Nephrotoxicity induced by vascular endothelial growth factor inhibitors." Journal of Nephropharmacology 11, no. 1 (October 6, 2021): e4-e4. http://dx.doi.org/10.34172/npj.2022.04.
Full textGrechukhina, Katerina S., Natalia V. Chebotareva, and Tatyana N. Krasnova. "Nephrotoxicity of anti-angiogenesis drugs." Terapevticheskii arkhiv 92, no. 6 (July 9, 2020): 93–98. http://dx.doi.org/10.26442/00403660.2020.06.000672.
Full textNadar, Sunil, Ioannis Karalis, Eman Al Yemeni, Andrew Blann, and Gregory Lip. "Plasma markers of angiogenesis in pregnancy induced hypertension." Thrombosis and Haemostasis 94, no. 11 (2005): 1071–76. http://dx.doi.org/10.1160/th05-03-0167.
Full textBhavina, K., J. Radhika, and S. Sundara Pandian. "VEGF and eNOS Expression in Umbilical Cord from Pregnancy Complicated by Hypertensive Disorder with Different Severity." BioMed Research International 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/982159.
Full textCorrêa, Isis Paloppi, Rodrigo Ruano, Nilton Hideto Takiuti, Rossana Pulcinelli Vieira Francisco, Estela Bevilacqua, and Marcelo Zugaib. "Expression of angiogenic factors in placenta of stressed rats." Reproduction, Fertility and Development 24, no. 6 (2012): 851. http://dx.doi.org/10.1071/rd11202.
Full textFeng, Yan, Ying Li, Xinling Yang, Limin Han, Luning Wang, Shan Gao, Ruixue Yin, et al. "Direct evidence of VEGF-mediated neuroregulation and afferent explanation of blood pressure dysregulation during angiogenic therapy." Frigid Zone Medicine 1, no. 2 (December 1, 2021): 119–26. http://dx.doi.org/10.2478/fzm-2021-0015.
Full textAbraldes, Juan G., Yasuko Iwakiri, Mauricio Loureiro-Silva, Omar Haq, William C. Sessa, and Roberto J. Groszmann. "Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state." American Journal of Physiology-Gastrointestinal and Liver Physiology 290, no. 5 (May 2006): G980—G987. http://dx.doi.org/10.1152/ajpgi.00336.2005.
Full textEscalante, Carmen P., and Ali Zalpour. "Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers." Cardiology Research and Practice 2011 (2011): 1–8. http://dx.doi.org/10.4061/2011/816897.
Full textNemtsova, Valeriya D., Olena V. Vysotska, Hanna M. Strashnenko, Hanna M. Borodkina, Tetiana O. Utytskykh, and Yurii P. Balym. "PROGNOSTIC ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN THE CARDIOVASCULAR COMPLICATIONS DEVELOPMENT IN PATIENTS WITH POLYMORBID PATHOLOGY: THE COMBINED COURSE OF HYPERTENSION, TYPE 2 DIABETES MELLITUS AND SUBCLINICAL HYPOTHYROIDISM." Wiadomości Lekarskie 75, no. 12 (2022): 3025–30. http://dx.doi.org/10.36740/wlek202212122.
Full textZhang, Huiying, and Lei Zheng. "PM2.5 is a risk factor of hypertension: A study on regression model for risk factors of hypertension." Materials Express 12, no. 9 (September 1, 2022): 1241–46. http://dx.doi.org/10.1166/mex.2022.2225.
Full textGu, Jian-Wei, R. Davis Manning, Emily Young, Megan Shparago, Brandi Sartin, and Amelia Purser Bailey. "Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 297, no. 1 (July 2009): R142—R148. http://dx.doi.org/10.1152/ajpregu.90972.2008.
Full textKneedler, Sterling C., Lauren E. Phillips, Kayla R. Hudson, Katharine M. Beckman, Catalina A. Lopez Gelston, Joseph M. Rutkowski, Alan R. Parrish, Peter A. Doris, and Brett M. Mitchell. "Renal inflammation and injury are associated with lymphangiogenesis in hypertension." American Journal of Physiology-Renal Physiology 312, no. 5 (May 1, 2017): F861—F869. http://dx.doi.org/10.1152/ajprenal.00679.2016.
Full textPurwani, Rani, Eti Yerizel, and Efrida . "The Effect of the Extra Virgin Olive Oil Administration towards the Malondialdehyde and Vascular Endothelial Growth Factor Levels on the Hypertensive Pregnant Rats." International Journal of Research and Review 9, no. 6 (June 23, 2022): 238–44. http://dx.doi.org/10.52403/ijrr.20220626.
Full textKang, Duk-Hee, Yoon-Goo Kim, Takeshi F. Andoh, Katherine L. Gordon, Shin-Ichi Suga, Marilda Mazzali, J. Ashley Jefferson, et al. "Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor." American Journal of Physiology-Renal Physiology 280, no. 4 (April 1, 2001): F727—F736. http://dx.doi.org/10.1152/ajprenal.2001.280.4.f727.
Full textNeves, Karla B., Augusto C. Montezano, Ninian N. Lang, and Rhian M. Touyz. "Vascular toxicity associated with anti-angiogenic drugs." Clinical Science 134, no. 18 (September 2020): 2503–20. http://dx.doi.org/10.1042/cs20200308.
Full textSandrim, V. C., M. R. Luizon, T. C. Izidoro-Toledo, E. B. Coelho, H. Moreno, and J. E. Tanus-Santos. "Functional VEGF haplotypes affect the susceptibility to hypertension." Journal of Human Hypertension 27, no. 1 (December 22, 2011): 31–37. http://dx.doi.org/10.1038/jhh.2011.110.
Full textSitumorang, Putri Cahaya, Syafruddin Ilyas, Doni Aldo Samuel Siahaan, Martina Restuati, Endang Ratna Sari, Chairunisa Chairunisa, and Muhammad Faldhy Maliki. "Effect of Rhodomyrtus tomentosa Hassk. on HIF1α and VEGF expressions on hypertension placental." Journal of Pharmacy & Pharmacognosy Research 10, no. 6 (November 1, 2022): 1076–86. http://dx.doi.org/10.56499/jppres22.1517_10.6.1076.
Full textMahmoud, Estabraq A. "Expression of Vascular Endothelial Growth Factor in the Placenta of Iraqi Women Complicated with Hypertensive Disorder." INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY 12, no. 03 (June 30, 2022): 977–80. http://dx.doi.org/10.25258/ijddt.12.3.09.
Full textDhami, Abhinav, Latha Vichu, and Parveen Sen. "Macular edema secondary to malignant Hypertension managed with Intravitreal Bevacizumab." Nepalese Journal of Ophthalmology 11, no. 1 (September 3, 2019): 98–101. http://dx.doi.org/10.3126/nepjoph.v11i1.25444.
Full textChongsrisawat, Voranush, Paisarn Vejchapipat, and Yong Poovorawan. "Serum vascular endothelial growth factor per platelet count in patients with biliary atresia." Asian Biomedicine 4, no. 2 (April 1, 2010): 223–29. http://dx.doi.org/10.2478/abm-2010-0030.
Full textTew, W. P., N. Colombo, I. Ray-Coquard, A. Oza, J. del Campo, G. Scambia, and D. Spriggs. "VEGF-Trap for patients (pts) with recurrent platinum-resistant epithelial ovarian cancer (EOC): Preliminary results of a randomized, multicenter phase II study." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 5508. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.5508.
Full textLangenberg, Marlies H. G., Carla M. L. van Herpen, Johann De Bono, Jan H. M. Schellens, Clemens Unger, Klaas Hoekman, Hubert E. Blum, et al. "Effective Strategies for Management of Hypertension After Vascular Endothelial Growth Factor Signaling Inhibition Therapy: Results From a Phase II Randomized, Factorial, Double-Blind Study of Cediranib in Patients With Advanced Solid Tumors." Journal of Clinical Oncology 27, no. 36 (December 20, 2009): 6152–59. http://dx.doi.org/10.1200/jco.2009.22.2273.
Full textSteeghs, N., T. J. Rabelink, J. op ’t Roodt, E. de Koning, and H. Gelderblom. "Bevacizumab-related hypertension: Search for underlying mechanisms." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e14520-e14520. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e14520.
Full textDiao, Xiaoyan, Kun Ding, and Xuemei Ma. "Efficacy of normodyne-magnesium sulfate combination treatment on pregnancy-induced hypertension, and its effect on VEGF and Flt-1 levels." Tropical Journal of Pharmaceutical Research 20, no. 10 (November 21, 2021): 2155–61. http://dx.doi.org/10.4314/tjpr.v20i10.20.
Full textPartovian, Chohreh, Serge Adnot, Saadia Eddahibi, Emmanuel Teiger, Micheline Levame, Patrick Dreyfus, Bernadette Raffestin, and Christian Frelin. "Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension." American Journal of Physiology-Heart and Circulatory Physiology 275, no. 6 (December 1, 1998): H1948—H1956. http://dx.doi.org/10.1152/ajpheart.1998.275.6.h1948.
Full textSchneider, Bryan P., Molin Wang, Milan Radovich, George W. Sledge, Sunil Badve, Ann Thor, David A. Flockhart, et al. "Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100." Journal of Clinical Oncology 26, no. 28 (October 1, 2008): 4672–78. http://dx.doi.org/10.1200/jco.2008.16.1612.
Full textTandon, Vibha, Swati Hiwale, Dnyanesh Amle, Tripti Nagaria, and Pradeep Kumar Patra. "Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients." Journal of Pregnancy 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/3179670.
Full textLiang, Songhe, Hao Yu, Xinxin Chen, Tingting Shen, Zhongqi Cui, JunTing Zhang, Yue Cheng, et al. "PDGF-BB/KLF4/VEGF Signaling Axis in Pulmonary Artery Endothelial Cell Angiogenesis." Cellular Physiology and Biochemistry 41, no. 6 (2017): 2333–49. http://dx.doi.org/10.1159/000475652.
Full textAl-Ghazali, Basima, Muna Khadim, Sara Hamza, Hawraa Sahib Al-Haddad, Alaa Salah Jumaah, and Najah Hadi. "Identification of vascular endothelial growth factor in preeclampsia in Iraqi women." Journal of Medicine and Life 15, no. 10 (October 2022): 1252–56. http://dx.doi.org/10.25122/jml-2021-0211.
Full textEl-Naggar, Abdel Rahman, Dalia Zaafar, Mohammed Elyamany, Soha Hassanin, Atef Bassyouni, and Hekma Abdel-Latif. "The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients." Journal of Cardiovascular Pharmacology and Therapeutics 24, no. 3 (January 10, 2019): 254–61. http://dx.doi.org/10.1177/1074248418817345.
Full textVoelkel, Norbert F., R. William Vandivier, and Rubin M. Tuder. "Vascular endothelial growth factor in the lung." American Journal of Physiology-Lung Cellular and Molecular Physiology 290, no. 2 (February 2006): L209—L221. http://dx.doi.org/10.1152/ajplung.00185.2005.
Full textLanzl, I., and K. Kotliar. "Können Anti-VEGF-Injektionen Glaukom oder okuläre Hypertension verursachen?" Klinische Monatsblätter für Augenheilkunde 234, no. 02 (February 22, 2017): 191–93. http://dx.doi.org/10.1055/s-0043-101819.
Full textKruzliak, Peter. "VEGF Pathway Inhibitors-Induced Hypertension: Next Step in Therapy." Journal of Clinical Hypertension 16, no. 8 (May 30, 2014): 617. http://dx.doi.org/10.1111/jch.12348.
Full textMoreau, Richard. "VEGF-induced angiogenesis drives collateral circulation in portal hypertension." Journal of Hepatology 43, no. 1 (July 2005): 6–8. http://dx.doi.org/10.1016/j.jhep.2005.04.002.
Full textBeaini, Shadia, Youakim Saliba, Joelle Hajal, Viviane Smayra, Jules‐Joel Bakhos, Najat Joubran, Dania Chelala, and Nassim Fares. "VEGF‐C attenuates renal damage in salt‐sensitive hypertension." Journal of Cellular Physiology 234, no. 6 (October 30, 2018): 9616–30. http://dx.doi.org/10.1002/jcp.27648.
Full textKhorram, Omid, Naseem Khorram, Mazdak Momeni, Guang Han, Jennifer Halem, Mina Desai, and Michael G. Ross. "Maternal undernutrition inhibits angiogenesis in the offspring: a potential mechanism of programmed hypertension." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 293, no. 2 (August 2007): R745—R753. http://dx.doi.org/10.1152/ajpregu.00131.2007.
Full text